I forsøg V var forbedringen i HAQ funktionsevneindeks og den fysiske komponent fra SF 36 større ke
In Study V, the improvement in the HAQ disability index and the physical component of the SF 36 showed greater improvement (p < 0.001) for Trudexa/ methotrexate combination therapy versus lP